KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short term Debt (2016 - 2020)

Historic Short term Debt for Neogenomics (NEO) over the last 12 years, with Q1 2020 value amounting to $5.0 million.

  • Neogenomics' Short term Debt fell 3649.18% to $5.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.0 million, marking a year-over-year decrease of 3649.18%. This contributed to the annual value of $5.0 million for FY2019, which is 3649.18% down from last year.
  • According to the latest figures from Q1 2020, Neogenomics' Short term Debt is $5.0 million, which was down 3649.18% from $5.0 million recorded in Q4 2019.
  • Neogenomics' Short term Debt's 5-year high stood at $8.8 million during Q1 2017, with a 5-year trough of $596000.0 in Q1 2016.
  • In the last 5 years, Neogenomics' Short term Debt had a median value of $5.0 million in 2019 and averaged $4.8 million.
  • In the last 5 years, Neogenomics' Short term Debt plummeted by 5771.79% in 2016 and then skyrocketed by 138221.48% in 2017.
  • Over the past 5 years, Neogenomics' Short term Debt (Quarter) stood at $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017, then soared by 109.95% to $7.9 million in 2018, then tumbled by 36.49% to $5.0 million in 2019, then changed by 0.0% to $5.0 million in 2020.
  • Its last three reported values are $5.0 million in Q1 2020, $5.0 million for Q4 2019, and $6.2 million during Q3 2019.